These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14424566)

  • 1. Potentiating the diabetogenic effect of alloxan by N-sulphonyl-N-butylurea (BZ-55).
    MOSINGER B; BRAUN T
    Experientia; 1959 Aug; 15():317-8. PubMed ID: 14424566
    [No Abstract]   [Full Text] [Related]  

  • 2. Pancreatic function in alloxan "subdiabetic" rats long-term treated with tolbutamide.
    WEBER JW; COLOMBO JP; GOLDBERG RI; SAPERSTEIN S; SHULKIND ML; KANAMEISHI D; FOA PP
    Diabetes; 1961; 10():122-9. PubMed ID: 13783629
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental studies on the effect of oral antidiabetic drugs. I. Estimation of plasma insulin-like activity in normal and alloxan diabetic rats with the rat diaphragm method].
    KUNO S
    Naika Hokan; 1961; 8():10-9. PubMed ID: 13755155
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of orally effective hypoglycaemic agents from plants on alloxan diabetes.
    BRAHMACHARI HD; AUGUSTI KT
    J Pharm Pharmacol; 1962 Sep; 14():617. PubMed ID: 13872406
    [No Abstract]   [Full Text] [Related]  

  • 5. [THE EFFECT OF N1-N-BUTYLBIGUANIDE ON OXYGEN AND GLUCOSE CONSUMPTION BY THE AORTA OF ALLOXAN DIABETIC RATS].
    LOOK D; WAHL P
    Klin Wochenschr; 1964 Apr; 42():398-400. PubMed ID: 14214536
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypoglycaemic activity of N-benzenesulphonyl-N'-iso-propylurea and N-benzenesulphonyl-N'-n-butylurea in experimental animals.
    TONSE U; ANANTHANARAYANAN KG; MHASALKAR MY; SHAH MH; DELIWALA CV
    Nature; 1962 Mar; 193():891. PubMed ID: 13921881
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin potentiating effect on development of alloxan diabetes and its prevention by the Ca-channel blocker nicardipine.
    Katsumata K; Miyao M; Katsumata Y
    Horm Metab Res; 1998 Sep; 30(9):557-8. PubMed ID: 9808323
    [No Abstract]   [Full Text] [Related]  

  • 8. Tolbutamide and the onset of alloxan diabetes in rats.
    KLIMAS JE; SEARLE GW
    Diabetes; 1958; 7(5):388-92. PubMed ID: 13574027
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of chlorpropamide on alloxan diabetes in mice.
    GRANDE F; MARTINEZ C
    Ann N Y Acad Sci; 1959 Mar; 74(3):817-9. PubMed ID: 13637622
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of BZ-55 and D-860 on normal and alloxan-diabetic laboratory animals].
    STEWART GA
    Ann Endocrinol (Paris); 1957; 18(2):230-45. PubMed ID: 13458921
    [No Abstract]   [Full Text] [Related]  

  • 11. [Potentiation of the effects of exogenous insulin by N-(4-methylbenzenesulfonyl)-N'-butylurea and N1-n-butylbiguanide in the eviscerated animal].
    CREUTZFELDT W; DEUTICKE U; SOELING HD
    Klin Wochenschr; 1961 Aug; 39():790-5. PubMed ID: 13696432
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of diabetogenic hormones on blood sugar and pancreas of sulfonylurea treated animals.
    LAZARUS SS; VOLK BW
    Endocrinology; 1960 May; 66():702-11. PubMed ID: 14414810
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of N1-sulfanilylo-N2-n-butylcarbamide on course of alloxan diabetes in rabbits and on hyperglycemic factor (glucagon) in pancreatic extracts in dogs].
    CZYZYK A
    Pol Arch Med Wewn; 1957; 27(8):1057-67. PubMed ID: 13505313
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of antidiabetics on the fat metabolism of alloxan-diabetic rats].
    Reissert K; Rudas B
    Arzneimittelforschung; 1969 Jun; 19(6):1019-21. PubMed ID: 5820029
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of heparin combined with aspirin upon intragastric administration on the state of the insulin system in animals with alloxan diabetes].
    Ul'ianov AM; Tarasov IuA; Liapina LA
    Izv Akad Nauk Ser Biol; 1995; (3):372-5. PubMed ID: 7670355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental study of the effect of BZ 55 on normal and alloxan-treated rats; morphological changes, especially pancreatic changes].
    BELLENS R; CHRISTOPHE J; GEPTS W
    Ann Endocrinol (Paris); 1956 Jul; 17(2):278-90. PubMed ID: 13355057
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental study of the effect of BZ 55 on normal or alloxan-treated rats. II. Effect on blood sugar].
    BELLENS R; CHRISTOPHE J; GEPTS W
    Ann Endocrinol (Paris); 1956 Jul; 17(2):291-8. PubMed ID: 13355058
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-diabetic and hypolipidemic effects of extract from the seed of Gossypium herbaceum L. in Alloxan-induced diabetic rabbits.
    Uzzaman R; Ghaffar M
    Pak J Pharm Sci; 2017 Jan; 30(1):75-86. PubMed ID: 28603116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [RESEARCH ON THE MECHANISM OF ACTION OF DIMETHYLBIGUANIDE ON GLUCOSE METABOLISM IN RATS WITH ALLOXAN DIABETES].
    PAVEL I; SDROBICI D; CHISIU N; MIHALACHE N; BONAPARTE H; TANASESCU N
    Stud Cercet Med Interna; 1964; 38():431-5. PubMed ID: 14212660
    [No Abstract]   [Full Text] [Related]  

  • 20. [The influence of insulin on hyperlactacidemia in the course of alloxan diabetes and experimental dysthyroidism].
    Colev V; Sneer A; Dughir E; Papp E
    Rev Med Chir Soc Med Nat Iasi; 1976; 80(4):587-92. PubMed ID: 16296545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.